Study ID: CTSU C80803
Title:

Randomized Phase II Trial Of Pet Scan-Directed Combined Modality Therapy In Esophageal Cancer

Description:

The purpose of this study is to learn if it is possible to improve the outcomes for patients with esophageal cancer by using PET/CT scans to determine whether or not a particular chemotherapy regimen is showing any effect on the tumor. Participants in the study have been diagnosed with esophageal cancer. Participants in this study will receive chemotherapy, followed by chemotherapy along with radiation therapy, and then they will have surgery.

Location:
Fargo Region
Principal Investigator:
Preston Steen, MD
Disease:
Esophagus
Stage:
Phase II

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list